Total medical devices industry M&A deals worth $21.21bn were announced in the US in January 2021, with OptumInsight’s $13bn acquisition of Change Healthcare being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 238.8% over the previous month of $6.26bn and a rise of 307.1% when compared with the last 12-month average of $5.21bn.
The US held a 91.19% share of the global medical devices industry M&A deal value that totalled $23.26bn in January 2021.
In terms of M&A deal activity, the US recorded 25 deals during January 2021, marking a decrease of 19.35% over the previous month and a rise of 25.00% over the 12-month average.
US medical devices industry M&A deals in January 2021: Top deals
The top five medical devices industry M&A deals accounted for 94.3% of the overall value during January 2021.
The combined value of the top five medical devices M&A deals stood at $20.01bn, against the overall value of $21.21bn recorded for the month.
The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’ $1.23bn acquisition of Preventice.
4) The $635m acquisition of Capsule Technologies by Koninklijke Philips
5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.